中药苍薏饮治疗痰湿体质高血压患者的临床研究-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

中药苍薏饮治疗痰湿体质高血压患者的临床研究

Clinical study on the treatment of hypertensive patients with phlegm-dampness constitution by traditional Chinese medicine Cangyi Yin

ES评分 0 浏览量：212 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20260143
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2026, 10(3)
作者	张宝山,
作者单位	石河子市人民医院（八师总院）新疆石河子;
摘要	目的剖析痰湿体质高血压用中药苍薏饮的作用。方法 2024年4月-2025年9月本院收治痰湿体质高血压病人（N=82）。选择数字随机表法，均分82名病例，当中，试验组用中药苍薏饮，对照组行常规治疗。对比血压等指标。结果关于总有效率：试验组95.12%，对照组78.05%，差异显著（P＜0.05）。中医证候积分：治疗3个月后：试验组（2.04±0.36）分，对照组（4.81±0.72）分（P＜0.05）。收缩压和舒张压：治疗3个月后，试验组（122.92±8.61）mmHg、（74.35±6.22）mmHg，对照组（130.52±9.18）mmHg、（84.68±7.05）mmHg，差异显著（P＜0.05）。结论痰湿体质高血压病人用中药苍薏饮，其疗效、中医证候积分与血压均显著改善。
Abstract	Objective To analyze the effect of the traditional Chinese medicine Cangyi Yin on patients with hypertension of phlegm-dampness constitution. Methods From April 2024 to September 2025, 82 patients with hypertension of phlegm-dampness constitution were admitted to our hospital. Using the digital random table method, all 82 cases were evenly divided. Among them, the experimental group received the traditional Chinese medicine Cangyi Yin, while the control group received conventional treatment. The blood pressure and other indicators were compared. Results Regarding the total effective rate: the experimental group was 95.12%, and the control group was 78.05%, with a significant difference (P<0.05). The TCM syndrome score: after 3 months of treatment: the experimental group was (2.04±0.36) points, and the control group was (4.81±0.72) points (P<0.05). Systolic and diastolic blood pressure: after 3 months of treatment, the experimental group was (122.92±8.61) mmHg and (74.35±6.22) mmHg, while the control group was (130.52±9.18) mmHg and (84.68±7.05) mmHg, with a significant difference (P<0.05). Conclusion For patients with hypertension of phlegm-dampness constitution, using the traditional Chinese medicine Cangyi Yin, the therapeutic effect, TCM syndrome score, and blood pressure have all significantly improved.
关键词	苍薏饮；高血压；中医证候积分；痰湿体质
KeyWord	Cangyi Yin; Hypertension; TCM syndrome score; Phlegm-dampness constitution
基金项目
页码	108-110

参考文献
相关文献

[1] 帅雨杏,周莎,王良景,等. 中药配方颗粒治疗高血压用药规律的数据挖掘
[J]. 广州中医药大学学报,2025,42(7): 1809-1816.

[2] 黄小瑜,卢健棋,李泓潓,等. 国家专利中药复方防治高血压的用药规律
[J]. 广西医学,2025,47(9):1303-1309.

[3] Reduced mRNA and Protein Content of Rho Guanine Nucleotide Exchange Factor (RhoGEF) in Bartter’s and Gitelman’s Syndromes: Relevance for the Pathophysiology of Hypertension
[J]. American Journal of Hypertension,2024, 18(9):1200-1205.

[4] 李纳川,张红晓,张萌,等. 基于生物信息学分析原发性高血压的关键基因及治疗中药的预测
[J]. 中西医结合心脑血管病杂志,2025,23(4):487-495.

[5] 杨晓梅,林森林,陈登丰,等. 基于中医传承辅助平台和SPSS卡方分析探究中药方剂治疗眩晕高血压用药规律
[J]. 贵州科学,2025,43(5):55-60.

[6] 刘钰,徐峰. 基于数据挖掘的中药复方治疗失眠合并高血压病用药规律研究
[J]. 世界中西医结合杂志,2024,19(4): 668-674.

[7] 赵会林,丁天龙,林蓉,等. 基于 R语言数据挖掘探析国家专利数据库中近5年治疗高血压病的中药复方用药规律
[J]. 中医临床研究,2024,16(26):142-148.

[8] 梁志乐,陈国成,潘林平,等. 中药苍薏饮治疗痰湿体质高血压患者的临床研究
[J]. 国际医药卫生导报,2024,30(6): 1020-1024.

引用本文

张宝山. 中药苍薏饮治疗痰湿体质高血压患者的临床研究 [J]. 国际临床研究杂志. 2026; 10; (3). 108 - 110.

文献评论

相关学者

相关机构